Impact of modified albumin-bilirubin grade on survival in patients with HCC who received lenvatinib

Tada, T; Kumada, T; Hiraoka, A; Atsukawa, M; Hirooka, M; Tsuji, K; Ishikawa, T; Takaguchi, K; Kariyama, K; Itobayashi, E; Tajiri, K; Shimada, N; Shibata, H; Ochi, H; Yasuda, S; Toyoda, H; Fukunishi, S; Ohama, H; Kawata, K; Tani, J; Nakamura, S; Nouso, K; Tsutsui, A; Nagano, T; Takaaki, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Joko, K; Koizumi, Y; Hiasa, Y

Tada, T (corresponding author), Japanese Red Cross Himeji Hosp, Dept Internal Med, 1-12-1 Shimoteno, Himeji, Hyogo 6708540, Japan.

SCIENTIFIC REPORTS, 2021; 11 (1):

Abstract

We investigated the impact on survival of modified albumin-bilirubin (mALBI) grade versus Child-Pugh classification in patients with hepatocellular ca......

Full Text Link